offline
Amgen (AMGN) Q4 Earnings and Revenues Surpass Estimates
Amgen (AMGN) came out with quarterly earnings of $3.64 per share, beating the Zacks Consensus Estimate of $3.44 per share. This compares to earnings of $3.42 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 5.81%. A quarter ago, it was expected that this world's largest biotech drugmaker would post earnings of $3.51 per share when it actually produced earnings of $3.66, delivering a surprise of 4.27%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Amgen, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $6.20 billion for the quarter ended December 2019, surpassing the Zacks Consensus Estimate by 3.18%. This compares to year-ago revenues of $6.23 billion.
...
https://finance.yahoo.com/news/amgen-amg...10597.html
![[Bild: AMGNc1dl1613.png]](https://finviz.com/publish/013120/AMGNc1dl1613.png)
Amgen (AMGN) came out with quarterly earnings of $3.64 per share, beating the Zacks Consensus Estimate of $3.44 per share. This compares to earnings of $3.42 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 5.81%. A quarter ago, it was expected that this world's largest biotech drugmaker would post earnings of $3.51 per share when it actually produced earnings of $3.66, delivering a surprise of 4.27%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Amgen, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $6.20 billion for the quarter ended December 2019, surpassing the Zacks Consensus Estimate by 3.18%. This compares to year-ago revenues of $6.23 billion.
...
https://finance.yahoo.com/news/amgen-amg...10597.html
__________________
